The Solubilization and Extraction Parameters of Erythromycin from Aqueous Phase Into Mixed AOT/SB3-18 Reverse Micelle Phase

A liquid anionic-zwitterionic surfactant-based aqueous two-phase extraction was developed and applied for the extraction of erythromycin. Erythromycin solubilization from aqueous to reverse micelle phase was studied. Zwitterion SB3-18 surfactant was added to ionic solution of bis(2-ethylhexyl) sulfo...

Full description

Saved in:
Bibliographic Details
Main Authors: S. N., Mohamad Aziz, Mimi Sakinah, A. M.
Format: Article
Language:English
Published: Bangladesh University of Engineering and Technology 2017
Subjects:
Online Access:http://umpir.ump.edu.my/id/eprint/20605/1/The%20Solubilization%20and%20Extraction%20Parameters%20of%20Erythromycin%20from%20Aqueous%20Phase%20Into%20Mixed%20AOT-SB3-%2018%20Reverse%20Micelle%20Phase.pdf
http://umpir.ump.edu.my/id/eprint/20605/
https://www.banglajol.info/index.php/CERB/article/view/33806
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaysia Pahang
Language: English
Description
Summary:A liquid anionic-zwitterionic surfactant-based aqueous two-phase extraction was developed and applied for the extraction of erythromycin. Erythromycin solubilization from aqueous to reverse micelle phase was studied. Zwitterion SB3-18 surfactant was added to ionic solution of bis(2-ethylhexyl) sulfosuccinate sodium salt (AOT) to form an organic mixed micellar phase. Erythromycin was then added to the mixtures and two clear phases were formed. The parameters affecting erythromycin solubilization including AOT concentration (20.0 ? 120.0 g/L), zwitterion concentration (6.0 ? 16.0 g/L), NaCl concentration (0.0 ? 25.0 g/L) and aqueous pH (6.0 ? 9.0) were investigated via statistical software. Solubilization of erythromycin into mixed reverse micelle could be easily evaluated by the measurement of erythromycin concentration in the organic phase. The results showed that AOT and zwitterion concentration governed the erythromycin solubilization by a factor of 4.562 based on the Pareto chart.